| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $726.9M | +17.8% |
| Cost of Revenue | $199.6M | +32.9% |
| Gross Profit | $527.3M | +13.0% |
| R&D Expense | $172.2M | +11.1% |
| SG&A Expense | $113.4M | -20.1% |
| Operating Income | $609K | +101.0% |
| Pre-tax Income | $6.4M | +107.1% |
| Income Tax | $5.2M | +394.4% |
| Net Income | $1.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.8M | +14.6% |
| Short-term Investments | $51.4M | +24.5% |
| Accounts Receivable | $255.1M | +30.8% |
| Current Assets | $519.4M | +19.3% |
| Total Assets | $691.4M | +11.3% |
| Current Liabilities | $452.1M | +27.4% |
| Long-term Debt | $240.8M | -3.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.9M | +814.1% |
| Capital Expenditures | $3.3M | -12.6% |
| Investing Cash Flow | -$12.8M | +63.8% |
| Financing Cash Flow | -$36.3M | — |
| Free Cash Flow | $59.6M | +1833.6% |
| +101.3% |
| EPS (Basic) | $0.02 | +101.6% |
| EPS (Diluted) | $0.02 | +101.6% |
| Total Liabilities |
| $738.4M |
| +13.0% |
| Stockholders' Equity | -$47.0M | -44.0% |